First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL
Clinical trial NCT01004497 · COMPLETED
Trial details
- NCT number
- NCT01004497
- Sponsor
- The Catholic University of Korea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2014-04-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.